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Summary-The development of sensitive radioimmunoassays (RIA) for testosterone and oestradiol-17/I, 
utilising ‘251-radioligands, is described. Use of an homologous bridge at the same site of attachment, for 
both the radioligand and the steroidxarrier protein conjugate employed in raising antibodies, normally 
results in a loss of assay sensitivity and precision. This was overcome in the oestradiol assay by utilising 
an heterologous configuration at the site of attachment (1 la vs ll/?). In contrast, for testosterone, even 
though an homologous bridge and site of attachment was used for the radioligand and the steroidcarrier 
protein conjugate, a very sensitive assay with extremely high antibody titres (dilution of 1:2 x 10”) was 
achieved. This finding was repeated with a different antiserum suggesting that the “bridge binding” 
phenomenon may be related to the position of attachment to the steroid molecule. In addition, an 
antibody-Sepharose 4B affinity chromatography extraction procedure has been developed for both 
oestradiol and testosterone. This approach allows the measurement of very low concentrations of steroids 
from large volumes of a variety of biological fluids. As antibody-linked Sepharose 4B uses high 
concentrations of antibody, steroids of similar structure are extracted from biological fluids. However, 
the cross-reactivity of these related steroids are very low in the RIA’s, ensuring good specificity. 
INTRODUCTION 
Although a number of methods have been described 
for the measurement of steroid hormones [l] there is 
still a requirement for more precise and sensitive 
methods to assay these hormones in plasma or 
serum. This is especially relevant for the study of 
reproduction in domestic animals where the 
concentrations of oestradiol- 17/3 and testosterone in 
the peripheral circulation are extremely low [see 
reviews 241. 
An increase in RIA sensitivity has been achieved by 
using the higher specific activity r-emitting radio- 
nuclides such as “‘1 as opposed to /?-emitting 
radioisotopes. This approach also has the added 
advantage of the cost effective manner in which 
samples can be counted [5-81. A serious disadvantage 
however, of using radioiodinated labels is the affinity 
that the antibody may show, not only for the hapten, 
but for the bridge through which it is attached to the 
carrier protein. As reviewed recently [5,6] the 
“bridge-binding” phenomenon can be overcome by 
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using either an homologous bridge to different 
configurations at the same site of attachment to the 
hapten [9] or by using an heterologous bridge [7, lo]. 
The occurrence of “bridge binding” may also be 
affected by the position of attachment to the steroid, 
even when using an homologous bridge and site of 
attachment. The present paper describes our results 
using an homologous bridge, from different 
configurations at the same site of attachment, in the 
case of oestradiol, and an homologous bridge from 
the same site, in the case of testosterone. 
Even with the utilisation of these techniques for the 
development of sensitive assays, relatively large vol- 
umes of plasma or serum are still required to measure 
very low concentrations of steroids in the peripheral 
circulation of domestic animals [l 1, 121. Classical ex- 
traction procedures utilise a range of solvents nor- 
mally followed by chromatographic purification to 
remove cross-reacting substances. The large volumes 
of fluid (at least 3 ml) that have to be extracted 
necessitate the use of large quantities of solvents 
which, as well as being hazardous, costly and labori- 
ous, increases the risk of high assay blank values [8] 
and low recoveries. In this report we also describe the 
use of an affinity chromatography extraction 
procedure [13] and its incorporation into very sensi- 
tive RIA’s for the measurement of low concentrations 
of testosterone and oestradiol- 17/I. 
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EXPERIMENTAL 
Chemicals and glassware 
Testosterone-3-carboxymethyloxime (testosterone- 
3-CMO) was purchased from Steraloids, Croydon, 
U.K., and 17/I-oestradiol-I la-hemisuccinate and 
17/I-oestradiol-1 l/I-hemisuccinate were supplied by 
Upjohn Co. (Kalamazoo, Michigan, U.S.A.). Pig 
skin gelatin, merthiolate (thimerosal), sodium 
metabisulphite, chloramine-T and steroids, used in 
the standard curves and cross-reactivity studies, 
were purchased from Sigma Chemical Co. (Poole, 
Dorset, U.K.). Na ‘251 (carrier free) and tritiated 
steroids [1,2,6,7-3H]testosterone (3.4 TBq/mmol); 
[2,4,6,7,16,17 - 'Hloestradiol - 178 (5.4 TBq/mmol); 
[2,4,6,7-3H]oestrone (3.0 TBq/mmol); [ 1,2,6,7,16,17- 
3H]progesterone (3.9 TBq/mmol) and [ 1 ,2,6,7-3H]an- 
drostenedione (3.0 TBq/mmol) were obtained from 
Amersham International (Buckinghamshire, U.K.). 
All solvents (analar grade) and scintillation fluid, 
except for “aristar” ethanol (BDH Chemicals, 
Glasgow, U.K.) were purchased from Fisons Ltd. 
(Loughborough, U.K.). Sephadex G-25 (finemesh), 
LH20 and CNBr-activated Sepharose 4B were sup- 
plied by Pharmacia Fine Chemicals (Uppsala, Swe- 
den). 
Purity of the water and cleanliness of the glassware 
is of particular importance when measuring low 
steroid concentrations. Therefore the water was 
coarse filtered to remove particulate material, de- 
ionised and finally double glass distilled. The glass- 
ware, except the columns used for the affinity chro- 
matography, was washed in a Meile dishwasher, 
rinsed twice in distilled water and finally baked at 
200°C for 2 h in a laboratory oven. 
After assessing a number of different columns for 
use in the affinity chromatography extraction pro- 
cedure the most appropriate were those using 
1Omm dia (porosity 1) glass sinter discs (Schott 
Glass, U.K.). The sinter discs were inserted into soda 
glass columns 10 x 120 mm with 55 mm tapered out- 
lets. This size of column allows a large number 
(2 100) to be used simultaneously. 
Syntheses 
Syntheses of steroid conjugates were similar to 
those described by Nordblom et a1.[7]. 
Preparation of testosterone-3-CMO-histamine 
Testosterone-3-CM0 (0.0668 mmol) and tri- 
ethylamine (Sigma, 0.133 mmol) were dissolved in 
freshly-distilled dioxane (BDH, 3 ml) and the reac- 
tion mixture was cooled to 10°C. Iso- 
butylchloroformate (Sigma, 0.0734 mmol) was added 
resulting in the immediate formation of a white 
precipitate; the reaction mixture was stirred for an 
additional 30 min. Histamine (Sigma, 0.0668 mmol), 
dissolved in 2 ml dioxane plus 3 drops ‘of water, was 
added and the mixture was stirred overnight at 10°C. 
The reaction mixture was poured into water (40 ml) 
and the aqueous layer was extracted 6 times with 
CH2C12 (15 ml). The combined organic layer was 
dried with Na,SO, and concentrated to approx 500 ~1 
in uacuo. The concentrate was loaded onto a 
20 x 20 cm silica gel preparative thin layer chro- 
matography (TLC) plate (60F 254, 0.25 mm thick- 
ness; Merck, Darmstadt, West Germany) and devel- 
oped with CH2C12-CH30H-NH,OH (90 : 10 : 1 by 
vol). The plate was treated with fluorescent dye and 
visualised with a U.V. lamp showing three bands at RI 
0.26, 0.10 and at the origin. The unreacted 
testosterone-3-CM0 remained at the origin. The 
bands at R, 0.10 (band A) and 0.26 (band B) were 
scraped off the plate and extracted with ethanol 
(10 ml). The ethanol solutions were evaporated to 
dryness and the resulting materials radioiodinated as 
described below. Radioiodinated band A was bound 
by antibody to testosterone (as described in the 
Results section) and therefore proved to be the 
desired product. 
Preparation of 178-oestradiol-lla-succinyl-tyro- 
sinemethylester 
17/I-Oestradiol-1 la-hemisuccinate (0.030 mmol) 
and triethylamine (0.060 mmol) were dissolved in 
freshly distilled dioxane (5 ml) and the mixture was 
cooled to 10°C. Isobutylchloroformate (0.033 mmol) 
was added resulting in the immediate formation of a 
white precipitate. After the reaction had mixed for 
30min tyrosine methyl ester (TME, O.O30mmol), 
dissolved in dioxane (2 ml), was added and the 
reaction mixture was stirred overnight at 10°C. The 
mixture was poured into water (40ml) and made 
slightly acidic (pH 4.0) with dilute HCl. The aqueous 
phase was extracted 6 times with CH,Cl, (15 ml). The 
combined organic layer was dried with Na,SO, and 
concentrated to about 500~1 in vacua. The 
concentrate was loaded onto a 20 x 20cm pre- 
parative TLC plate and developed with 
CH2C12-CH,OH-CH,COOH (95 : 5 : 1, by vol). As in 
the case of the testosterone-3-CMO-histamine syn- 
thesis above, three bands were found. Unreacted 
17p -oestradiol-1 la -hemisuccinate remained at the 
origin. In addition, two bands were found at Rr 0.33 
(band A) and 0.63 (band B). The silica for each band 
was scraped from the plate and extracted with 
ethanol (10 ml). When the material from band A was 
radioiodinated as described below the label was 
bound by the oestradiol-178 antibody as described in 
the Results section. 
Preparation of 17/?-oestradiol-llp-succinyl-tyro- 
sinemethylester 
This was prepared as described for the 17/I- 
oestradiol-1 la-TME except that 17B-oestradiol- 
11/I-hemisuccinate was used. As for the 17/I- 
oestradiol- 11 a -TME separation by TLC following 
synthesis gave three bands. Unreacted oestradiol- 
llfl-hemisuccinate remained at the origin. In 
addition there were two bands at R, 0.29 (band A) 
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and 0.57 (band B). Furthermore, as for the 
17/I-oestradiol-1 lx-TME, when band A was 
radioiodinated, see below, the label was bound by the 
oestradiol antibody as described in the Results 
section. 
Preparation of 17/I-oestradiol-1 l/3-succinyl-bovine 
serum albumin 
17/I-Oestradiol-1 lbhemisuccinate (0.023 mmol) 
was dissolved in dimethyl formamide (2ml) and 
H,O (1 ml). I-Ethyl-3-(3-dimethyl-aminopropyl)- 
carbodiimide (0.192 mmol) was added and the 
mixture stirred for 30 min. Bovine serum albumin 
(36mg), dissolved in sodium phosphate buffer 
(0.02 M, pH 7.8, 10 ml), was added dropwise to the 
steroid solution and stirred for 4 days at room 
temperature in the dark. The reaction mixture was 
dialysed against 0.05 M NaHCO, (2 x 500 ml) and 
HZ0 (2 x 500ml) and subsequently dried by 
lyophilization. 
Radioiodination 
Iodination of the testosterone-3-CMO-histamine, 
17/I-oestradiol-1 lcr-TME and 17/I-oestradiol-1 l/I- 
TME were carried out as described previously by 
Hunter et al. [14]. Aliquots of the steroid derivatives 
(2pg) were stored in 10~1 ethanol (aristar) at 
-50°C. Prior to iodination the solvent was evapo- 
rated to dryness under N, and the steroid conjugate 
was then reconstituted in 40 ~1 phosphate buffer 
(0.5 M, pH 7.5). 
Aqueous Na [L25I] (37 MBq, 10 ~1) was added. The 
reaction was initiated by the addition of chloramine- 
T (lO~g/lO~l in 0.05M sodium phosphate buffer, 
pH 7.5). After mixing and incubation at ambient 
temperature for 2 min the reaction was quenched by 
the addition of sodium metabisulphite (10 pg/lO ~1 in 
0.05 M phosphate buffer, pH 7.5). 
In the case of the oestradiol-17/-I derivatives the 
reaction mixture was transferred to a 10 x 200 mm 
Sephadex G25 (fine mesh) column, previously 
swollen in 0.05 M phosphate buffer (pH 7.5). The 
iodinated steroid was eluted under pressure using a 
peristaltic pump, with 0.05 M sodium phosphate 
buffer (pH 10.5). Approximately 1 ml aliquots were 
collected directly into glass tubes containing 200 ~1 
phosphate buffer (0.5 M, pH 7.5). The first peak 
eluted was discarded and the second peak, normally 
fractions 20-30, were pooled and adjusted to pH 7.5 
and stored at 4°C. The specific activity of the label 
was assessed as described previously [5,7] and was 
found to be approx 48 TBq/mmol. The shelf-life of 
the material was at least 60 days. 
In the case of the testosterone derivative, following 
iodination, the reaction volume was increased to 
500~1 by addition of phosphate buffer (0.05 M, 
pH 7.5) and then transferred to a tapered glass 
stoppered centrifuge tube. The iodinated derivative 
was extracted by mixing for 1 min with 500 ~1 ethyl 
acetate. The solvent phase was transferred to a 
second glass vial and the reaction mixture extracted 
for a second time. The combined solvent was then 
evaporated to a vol of 200 ~1, by incubating in a 
water bath at 40°C under a stream of air. The 
concentrated preparation was then loaded onto a 
plastic backed silica gel TLC plate (20 x 20 cm) as a 
continuous streak. The plate was developed in 
CH,CL,-CH,OH-CH,COOH (90 : 10: 1, by vol) for 
approx 2 h. The plate was scanned, using a min- 
imonitor and the required band (R, 0.8) was cut out 
and the iodinated steroid eluted by incubating over- 
night in ethanol (aristar) at 4°C. Two other bands at 
the origin and just behind the solvent front were 
discarded. The ethanol was filtered through a Pasteur 
pipette containing glass wool to remove particulate 
silica gel. The material was stored at 4°C until use, the 
shelf life of the label being usually at least 90 days. 
The specific activity of the label was found to be 
approx 63 TBq/mmol. 
Recently one of the authors (G. D. Nordblom, 
pers. commun.) has developed an HPLC procedure 
for purifying the radiolabelled testosterone and 
oestradiol-1 lcr-TME derivatives. Purification was 
performed on an Altech 600 RPA C,, reverse phase 
column. The entire radioiodination reaction mixture 
was injected on the column using a Rheodyne injector 
fitted with a 100~1 loop. A Spectra-Physics 8700 
pump and solvent delivery system provided the fol- 
lowing mobile phase at a flow rate of 1 ml per min: 
for oestradiol-17fl; @-5 min, an isocratic mixture of 
20% CH,CN (A), 80% 0.05 M potassium formate 
buffer, pH 4.0 (B), 5-55 min, a 2045% gradient of A; 
55-80 min, a 45-70% gradient of A; for testosterone; 
0.5 min an isocratic mixture of 20% A and 80% B, 
5-80 min, a 2060% gradient of A. 
The elution pattern of the oestradiol-17/I label 
consisted of free iodine at 3 min, monoiodinated 
TME at 52 min and diiodinated TME at 54min. 
Several other peaks at 61,64,69 and 74 min were also 
eluted. The material in these peaks was not bound 
by antibody to oestradiol and undoubtedly corre- 
spond to derivatives that are iodinated on the A-ring 
of the steroid. The elution pattern of the testosterone 
label consisted of free iodide at 3 min and peaks at 56, 
59 and 65 min all three of which were bound by anti- 
body to testosterone and are probably due to 2-iodo, 
5-iodo and 2,5-diiodo derivatives of the imidazole 
ring of the histamine functional group. 
Antisera 
The testosterone antisera used in the RIA and also 
the oestradiol and testosterone antisera used for 
linking to the CNBr-activated Sepharose 4B were 
raised in sheep as described previously [16]. The 
oestradiol- 178 antisera used in the radio- 
immunoassay was raised in rabbits against 
17/I-oestradiol-1 lfl-succinyl-bovine serum albumin 
(BSA) in collaboration with H. M. Fraser and 
A. McNeilly (MRC, Reproductive Biology Unit, 
Edinburgh). Rabbits were injected intra-dermally 
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with 150 fig llffi-oestradiol-1 la-succinyl-BSA in a 
2 ml emulsion of saline: Freunds complete adjuvant 
(ratio 2:3). The animals were then boosted at approx 
3 month intervals with Soling of oestradiol conju- 
gate in a 2 ml emulsion of saline: Freunds incomplete 
adjuvant (ratio 2:3). Animals were bled at weekly 
intervals following boosting and the different pools of 
serum characterised. The anti-oestradiol- 178 serum 
used from rabbit 32 (Table I) was collected following 
the first booster injection and anti-oestradiol- I 78 
serum from rabbit 48 (Table 1) was collected follow- 
ing the second booster injection. Specificity of the 
antisera used in the radioimmunoassays was 
estimated by measuring 50% displacement of the 
label by the other steroids [ 17,181. 
Ovine oestradiol-17~ and testosterone antisera 
were covalently coupled to CNBr-activated Sephar- 
ose 4B using the meth~doiogy recommended by the 
manufacturer. Briefly 9 g (dry weight) of Sepharose, 
swollen to give approx 35 ml slurry, was placed on a 
grade 3 sintered glass filter funnel and washed with 
1800 ml of 1 mM HCl. The slurry was then trans- 
ferred to a 50 ml ground glass stoppered test-tube 
containing 150 pl of antiserum, in 18 ml of coupling 
buffer (NaHCO,, 0.1 M; NaCI, 0.5 M; pH 8.3). The 
solution was mixed overnight at 4°C on an end over 
end mixer. Unbound material was removed by wash- 
ing with 50ml coupling buffer on the sintered glass 
filter funnel. Remaining residual active groups on the 
Sepharose were blocked by incubating with 200ml 
ethanolamine (1 M, pH 9.0) for 2 h at ambient tem- 
perature. Non-covaiently bound material was re- 
moved by four alternate washes with high (borate 
buffer, 0.1 M, pH 8.0) and low (acetate buffer, O.lM 
pH 4.0, containing 0.5 M NaCl) pH buffers. Finally 
the antibody bound Sepharose was washed, re- 
suspended and stored at 4°C in 75ml phosphate 
buffered saline (0.05 M, pH 7.5, 0.01% thimerosal) 
ready for use. 
Approximately 1,000 cpm of the appropriate triti- 
ated steroid (10~1 diluted in ethanol) together with 
the appropriate sample (5-3,OOO~Cri) were pipetted 
into screw-capped glass culture tubes (16 x 125 mm), 
mixed and incubated for 30 min at room temperature. 
A further IOmi of double distilled Hz0 was then 
added to each tube, followed by 5OOgl of antibody- 
Sepharose. It was later found that as little as SO@1 
of antibody-Sepharo~ could be used therefore negat- 
ing the need for recycling. The samples were then 
mixed end over end, for at least 2 h at room 
temperature or overnight at 4°C. The contents of 
each tube were poured directly on to prewashed 
sintered gfass columns and the aqueous waste dis- 
carded. The antibod~sepharo~ residues in the tubes 
were then rinsed with 7 ml Hz0 and again poured on 
to the respective columns. The antibody-Sepharose in 
each column was washed with 20mI Hz0 and the 
eluates allowed to run to waste. Residual water in the 
system was then removed by applying slight positive 
pressure using an aquarium pump. Bound hormone 
was then eluted with 3 ml CH,OH-H,O (90: 10, v/v), 
Positive pressure was applied to ensure rn~irn~ 
elution of the solvent into glass test tubes 
( 125 x 16 mm). The eluate was evaporated to dryness 
in a Buchier Vortex evaporator at 40°C (Gal- 
lenkamp). The hormone extracts were reconstituted in 
1800 .u 1 phosphate buffered saline, containing 0.1% 
gelatin (PBS-Gel), and then mixed for at least 20 min 
on a Vortex evaporator (37°C). Recovery was as- 
sessed as a percentage of total counts by taking a 
500~1 aliquot of the reconstituted material and 
counting on a liquid scintillation counter (LKB, 
Rackbeta 1211). For example mean recovery for 
testosterone was 81.4% (c.v. =4.0%, IZ = 160) and 
for oestradiol-17/I 76.9% (c.v. = 6.0%, n = 154) over 
several assays. 
Two 5~~1 aliquots of the extracted and recon- 
stituted steroid were then removed for radio- 
immunoassay. As the tritiated label used for recovery 
estimates does not interfere with gamma counts, 
individual recovery estimates were routinely made. 
However, because of the sensitivity of the assays (see 
Results section) correction was made for the weight 
of steroid added in the recovery counts. 
After use the residual antibody_Sepharose was 
resuspended in 7 ml Hz0 and the slurry from each 
column pooled in a large sintered glass funnel (poros- 
ity 3) and recycled by 3 alternate washes in CH@H 
and H,O. The material was found to be very stabfe 
and was recycled, without loss of binding activity, 
at least 50 times over a 2 year period. However, 
it has been estimated that a 15 g batch of Sepharose 
provides enough material to extract over 2OOO sam- 
ples (50 yl antibody-Sepharose) thereby reducing the 
need to recycle the material. 
Some of the validation experiments (see Results 
section) also employed a solvent extraction pro- 
cedure. In these cases the samples, which had pre- 
viously been eq~librat~ with recovery label, were 
extracted with either 15 ml (oestradioi-178) or 3 ml 
(testosterone) diethyl ether by mixing for 15 min on 
a multivortexer (SMI). The aqueous phase was frozen 
in a dry ice-methanol bath and the solvent phase 
decanted into glass tubes (125 x 16 mm) and evapo- 
rated to dryness in a Buchler vortex evaporator. The 
sample was then reconstituted in either assay buffer 
or Hz0 prior to assay or affinity chromato~phy 
extraction respectively. 
Radioimmunoassay 
The steroid standards (5OOpg~ml) or unknown 
samples were dissolved in assay buffer (PBS-gel) and 
dispensed in duplicate or triplicate and made up to a 
constant volume of 500 ~1 in assay buffer. A IO0 al 
aliquot of iodinated steroid (approx 20,000 counts 
per 100 s) was then added immediately followed by a 
2OOj~l aliquot of first antibody at an appropriate 
dilution (see Table 1). The assay was then incubated 
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Mass of steroid for 
Final Percent of Slope of 50% displacement 
antibody label bound inhibition of bound label 
Titre (x IO-)) (%) curve (pgwe) 
Sheep 501 oestradiol-6-CMO* 17/3-oestradiol-llcr-TME I:120 49 200 
Sheep 614 oestradiol-3-CME$ I7/3-oestradiol-1 la-TME I:28 37 
: 
400 
Rabbit 32 oestradiol-I lb-H5 l7g-oestradiol-I la-TME I:200 40 -0.82” 20 
Rabbit 48 oestradiol-I IS-H 178 -oestradiol- I I a -TME I:160 38 - I .09y 5 
Rabbit 32 oestradiol-I lb-H l7)?-oestradiol-llfl-TME I:200 38 -0.60’ 125 
Rabbit 48 oestradiol-I I/?-H 178-oestradiol-llg-TME I:160 62 -0.731 96 
Sheep 505 testosterone-3-CM0 testosterone-3-CMO-histamine I : 2800 82 -0.99 40 
Sheep 506 testosterone-3-CM0 testosterone-3-CMO-histamine I : 2800 84 -1.2 28 
‘Carboxymethyloxime; tBinding was inhibited over a very small range (see text for details); fcarboxymethyl ether; §Hemisuccinate. w 
versk x and y versus z are significantly different (P 2 0.001). 
at room temperature for approx 2 h followed by the 
addition of previously optimised precipitating re- 
agents. These included 100 ~1 normal sheep or rabbit 
serum, depending on first antibody, and 100 ~1 of 
second antibody (raised in donkeys to either sheep or 
rabbit IgG) diluted in PBS gel, containing 
0.1 M EDTA. Following an overnight incubation at 
4°C 2 ml of ice-cold PBS gel was added and the tubes 
centrifuged at 800g for 30 min (4°C). The super- 
natants were immediately decanted to waste, tubes 
drained for 15 min and the radioactivity in the precip- 
itates counted on a gamma counter LKB (80,000 
Series Wallac or LKB 1271 Riagamma). 
Analysis of results 
The assay results were computed by the ABRO 
RIA program package based on the method of 
Rodbard and Lewald [19]. Scatchard analysis [20] of 
results was carried out by the RIA programme 
package, but were also re-calculated following cor- 
rection for non-specific binding [2 1,221. Significance 
of differences between the slopes of the standard 
curves and Scatchard plots were calculated by com- 




Titres. The antibody titres and the various io- 
dinated labels used are shown in Table I. The most 
sensitive oestradiol assays were developed by using an 
heterologous configuration assay system consisting of 
17/l-oestradiol-1 lcr-TME label with an antibody 
raised against 17/l-oestradiol-1 I/?-BSA. For both of 
the oestradiol antisera tested the use of an 
17/l-oestradiol-1 I/?-TME label shifted the slope to 
the right, i.e. the weight of hormone required to 
inhibit binding was markedly increased. Also the 
slope of the standard curve was significantly shal- 
lower than the ideal - 1.00, as would be expected 
from classical “bridge binding” theory [5, 61. 
Although 5 antisera, raised against oestradiol- 178 
conjugated at the three or six positions, were tested 
for their ability to bind to iodinated oestradiol-17/l 
(17p-oestradiol-1 lx-TME) only two antisera, sheep 
501 and 614 (Table I), were capable of binding the 
label. Binding of the iodinated label by these two 
antisera could be inhibited with unlabelled oestradiol. 
However, inhibition did not occur until at least 50 pg 
of oestradiol had been added and then occurred over 
a narrow range (sheep 501: between 5&100 pg; sheep 
614: between 100-500 pg), thereby producing abnor- 
mal standard curves. 
For the testosterone assay an homologous assay 
system (same chemical bridge and site of attachment) 
was used. Although extremely high titres were 
achieved (Tables 1 and 2), suggesting a “bridge 
binding” phenomenon, the label was capable of being 
displaced with unlabelled hormone (Table 2). 
Therefore at extremely high antibody dilutions very 
sensitive assays were obtained with both antisera. 
From these initial studies rabbit 48 for the 
oestradiol- 178 assay (using 17/l -oestradiol-1 1 a-TME 
label), and sheep 505, for the testosterone assay 
(using testosterone-3-CMO-histamine label), were 
characterised further and then incorporated with an 
affinity chromatography extraction procedure. 
Table 2. Binding characteristics of testosterone antiserum (sheep 505) at three dilutions 
Mass of 
steroid for 50% 





Dissociation total label 
(x 10-q 
of bound label 
curve constant (M) bound (%) (PP) 
1: 2,800’ -1.25 (a) 1.9 x IO-“a 82 37 
-0.93 (b) 1.1 x IO-‘Ob 
I : 10,000 -1.15 1.2 x lo-” 55 10 
1: 20,000 - I .03 1.4 x lo-” 48 5 
*Two populations of antibodies (see Fig. 1) and overall slope of the inhibition curve = - 1.07. 
a versus b P <O.OOl. 
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Fig. 1. Scatchard analyses of (A) oestradiol antiserum (rabbit 48) tested at a final dilution of 1: 200,000 
and (B) testosterone antiserum (sheep 505) tested at a final dilution of 1:2,800,000. 
antibody a~~ities. Scatchard analysis of the 
oestradiol-17/I inhibition curve (rabbit 48) demon- 
strated that at the antibody dilution used there 
appeared to be only one population of binding sites 
with a dissociation constant (&) of 9.4 x IO-‘* M 
(Fig. I). When the testosterone antiserum (sheep 505) 
was tested at a lower antibody dilution (final dilution 
of 1:2.8 x 106) two populations of antibodies were 
found (Fig. 1) which produced significantly different 
(P < 0.001) slopes (Table 2). However, when tested at 
two higher dilutions (Table 2) only the high affinity 
antibodies were detected. However, the slope of the 
inhibition curves were similar when the antiserum 
was tested at three dilutions. Both the oestradiol-17fl 
(rabbit 48) and testosterone assays [sheep 5051 (Fig. 
1) were very sensitive when used at the higher dilu- 
tions, giving a minimum detectable dose of approx 
8OOfg per tube. As the testosterone antibody was 
still binding 50% of the label this assay could 
probably be made even more sensitive by diluting the 
antiserum further. 
Antibody specificity. All 3 antisera demonstrated 
good specificity (Table 3). Antiserum from rabbit 48 
had a 16% cross-reactivity with oestrone, but En- 
gland et a/.[91 have previously demonstrated that very 
specific antisera can be obtained when oestradiol- 178 
is conjugated to the carrier proteins through the 1 l&3 
position. This is supported by the results using anti- 
serum from rabbit 32 which showed only a 2% 
cross-reaction with oestrone. Antiserum from sheep 
505 also showed good specificity, with only a 12% 
cross-reaction with Sa-dihydrotestosterone. 
Afinity chromatography 
Extraction specificity. The specificity of the 
antibody-Sepharose was assessed by incubating with 
various tritiated steroids (Table 4). The results 
demonstrate that the method does provide some 
specificity, with progesterone showing very low cross- 
reaction for both the testosterone and oestradiol 
linked antibodies. However, because of the high 
antibody concentrations, more closely related ste- 
roids were bound by both the testosterone and oe- 
stradiol antibody-~pharose. The results also demon- 
strate that 2 or 3 washes with water, of the 
antibody-Sepharose, removed virtually all of the un- 
bound steroid. A 3 ml wash with 90% methanol was 
also very efficient at removing the antibody bound 
steroid. The results indicate that residual steroid 
contaminatjon is negligible, therefore aIlowing re-use 
of the antibody-Sepharose if required (131. 
Comparison of extraction procedures. Several meth- 
ods of extraction of both testosterone (Table 5) and 
oestradiol (Table 6) were compared. Affinity chro- 




Rabbit Rabbit Sheep 
Steroid tested 32 48 505 
Oestradiot 178 100 100 0.01 
oestrone 3.2 16 0.0 1 
oestriol 1.6 3.0 0.0 I 
Testosterone 3.2 1.2 loo 
Sa-Dihydrotestosterone 0.3 0.1 12.1 
Androsterone 0.1 0.0 I 3.3 
Androstcnedione 0.1 0.1 0.9 
S-Androsten-3g-ol-17-one - 
Progesterone 0.8 tG1 
0.6 
0.0 I 
Antisera 32 and 48 were tested using the heterologous system 
(oestradiol-1 la tyrosine methyl ester label) at final dilutions of 
1:200,000 and 1: 16&000 respectively. Sheep 505 was tested at a 
final antibody dilution of 1: 2.8 x IO’. The following steroids also 
had < 1.0% cross reaction with all three antisera: 
5.androstan-3/f.17/?-dial; cortisol, corticosterone, etiocholan-3e- 
ol-17.one; 5-pregnen-16e-ol-3,20-dione; 4-pregnen-l7cl-01-3.20 
dione; 4-pregnen-20x-ol-3-one; 4-pregen-16x-01-3.20 dione. 
Measurement of low concentrations of steroids 1049 
Table 4. Percentage recovery of various tritiated steroids following extraction with either oestradiol antibodies or testosterone antibodies 
linked to Sepharose 4B 
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87. I 0.6 103.7 
2.0 0.0 98.0 
53.2 0.3 96.5 
6.6 0.1 loo.2 
65.3 3.5 92.9 
16.9 0.1 I0l.l 
5.7 0.1 98.0 
76.8 1.9 91.6 
Testosterone Androstenedione 15.5 1.7 I.1 18.3 72.6 1.8 92.7 
Table 5. Comparison of three methods of extraction of testosterone from ovine follicular fluid 
Mean percentage 






(ngjml f SEM) Method of extraction 
Solvent followed by 
affinity chromatography 79.6 f I .3 -0.98 33.3 + 2.9 
Solvent only 90.2 + 2.3 -0.97 31.9 f 2.4 
Affinity chromatography only 92.5 f I .O - 0.95 30.6 f 3.0 
Each sample was assayed at 4 vol in quadruplicate, using sheep 505 antiserum, with duplicate 
recovery estimates at each level. The 50% inhibition point and slope of the inhibition curve 
was 40pg/tube and -0.91 respectively. All samples were parallel to the standard curve. 
matography gave satisfactory results, since there was 
no significant differences in mean hormone concen- 
trations between the various extractions methods and 
the samples were parallel to the inhibition curve. 
Moreover, the results were in agreement with fol- 
licular fluid oestradiol- 1.78 concentrations measured 
without previous extraction [23]. Use of affinity chro- 
matography to extract known amounts of oestradiol- 
178, from various volumes of ovine serum, gave good 
recoveries (Table 7). As a further assessment of the 
effect of different sample volumes the recovery of 
exogenous oestradiol and testosterone, added to ovine 
serum, was measured. For oestradiol, 100 pg/ml 
added to ovariectomised ewe plasma was assayed at 
4 vol, (150, 250, 500 and 1000 ~1) in duplicate. Mean 
concentrations of oestradiol recovered were 99.7, 
111.9, 98.9 and 102.2 pg/ml respectively. The sample 
Table 6. Comparison of different extraction procedures of 
oestradiol- 176 from ovine follicular fluid 
Inhibition Mean oestradiol 
Method of Mean percentage slope of concentrations 
extraction recovery ( f SEM) sample (ng/ml f SEM) 
Solvent followed 
by affinity 63.8 f 0.9 - 1.34 30.5 f 4.4 
chromatography 
Affinity 
chromatography 70.7 + I .4 -1.28 27.6 f 3.0 
only 
Direct assay - - I.35 30.1 + 3.4 
Each sample was assayed at 5 levels in duplicate, with individual 
recovery corrections, using rabbit 48 in the heterologous assay. 
The 50% inhibition point and slope of the inhibition curve was 
5.2 pg/tube and - I .2 respectively. All samples were parallel to 
the standard curve. 
was parallel to the standard curve, the slopes being 
- 1.15 and - 1.25 respectively. For testosterone 10, 
50, 100 and 200 pg was added to four 3 ml aliquots 
of ovine plasma and the amount of testosterone 
recovered was 9.4 f 1.5; 49.8 f 2.5; 102.5 f 8.9; 
216 f 8.4 pg respectively. Testosterone was also as- 
sayed in 4 vol(50; 100,250 and 500 ~1) of ram plasma 
following affinity chromatography extraction. The 
amount of testosterone measured was 3.5, 3.6, 3.5 
and 3.5 ng/ml respectively. The sample was also 
parallel to the standard curve, the slopes being - 0.96 
and -0.99 respectively. In both the oestradiol and 
testosterone assays the assays blanks were always 
undetectable. 
DWCUSSION 
The results described here support the previous 
conclusion [5,6] that the use of an heterologous 
configuration at the site of attachment significantly 
reduces the recognition of the chemical bridge by 
the antibody. This was found using two antisera 
Table 7. Extraction of oestradioLl7j from ovine serum using an 
affinity chromatography extraction procedure 
Quantity of Mean concentration of 
oestradiol-17/I Sample volume 
added (pg) 
oestradiol- 178 recovered 
W) (pg f SEM) 
IO I 000-3000 10.9 f 0.5 
50 250-900 49.5 * I.1 
100 150-1000 103.2 + 3.0 
Each sample was assayed in duplicate using 3 or 4 vol within the 
range shown. The concentration of oestradioLl7jI in the control 
serum was I .6 f 0.2 pg/ml. 
1050 R. WEBB et al. 
(Table 1) raised against 17fi-oestradiol-1 lb-BSA. [9]. 
Furthermore, the slope of the inhibition curve was 
significantly steeper when using the heterologous 
compared to the homologous configuration of at- 
tachment, leading to increased assay sensitivity and 
precision [S, 61. However, if the site of attachment 
was too remote (3 and 6 positions), although two of 
the antisera could bind the label, the inhibition curves 
were not usable (Table 1). 
The results described here also extend these 
findings and indicate that the occurrence of “bridge 
binding” may also be affected by the actual position 
of attachment to the steroid molecule. Although an 
homologous chemical bridge and site of attachment 
(3 position) were utilised in the testosterone assay a 
suitable slope, similar to the oestradiol-17/I system, 
was achieved. Moreover, because similar results were 
obtained using antisera from two different animals 
this may be a common mechanism, rather than due 
to the individual characteristics of a single antiserum. 
This conclusion is supported by a previous in- 
vestigation of a number of steroids [24], although 
exact titres and inhibition curves were not shown. 
Why this phenomenon should apply to the 3 
position of the steroid molecule and whether it is 
related to molecular folding and spatial relationships 
between hapten and carrier protein remains to be 
determined [6]. Interestingly, the extremely high titres 
of the testosterone antibodies (Tables 1 and 2) 
suggests a high affinity for the radiolabel. Previous 
results with androstenedione [7; unpublished data] 
indicated that very high antibody titres can be 
achieved when an’homologous system is used. Nor- 
mally however, the radiolabel is not easily displaced 
from the antibody. 
The Scatchard analyses indicated the presence of a 
high affinity binding site in both the oestradiol-178 
and testosterone antisera (Fig. 1, Table 2). However, 
two significantly different binding affinities were ap- 
parent (Fig. 1) in the testosterone assay when tested 
at high antibody concentrations. Two possible alter- 
natives are either the presence of two pools of 
antibodies or an antibody with divalent 
characteristics [25], as described for monoclonal anti- 
bodies raised against deoxycorticosterone [26]. The 
Scatchard analysis and slope of the testosterone 
inhibition curves demonstrated that at the high anti- 
body dilutions (Table 2) only the high affinity binding 
site was of importance. 
The cross-reaction studies suggest that utilising the 
11 position for oestradiol-17/I can lead to specific 
antisera (Table 3) and is in agreement with the 
previous work of England et aL[9]. The testosterone 
assay also demonstrated good specificity (Table 3). 
There was some cross-reactivity with Scc-dihydro- 
testosterone, but antibodies have been shown to have 
problems in differentiating between the 4-ene and 56! 
reduced forms of androgens [7,27-301. The specificity 
achieved in our assay system was better than that 
quoted by Cameron et al. [24], but this could be 
related to antibody concentration as this does have a 
SignifiCant effect on steroid antibody specificity [3 11. 
Recently monoclonal antibody techniques have been 
used to produce a specific testosterone antibody [321. 
although monoclonal antibody affinities tend to be 
lower [32,33]. 
Steroid antibody cross-reactivities are further high- 
lighted by the specificity of the antibody-Sepharose 
(Table 4), where the antibody concentrations are 
high [31]. In agreement with the results of Glencross 
et a/.[ 131 the oestradiol- 17p antibody-Sepharose and 
also the testosterone antibody-Sepharose had low 
cross-reactivity with progesterone. Although Glen- 
cross et aZ.[13] reported no other cross-reactivities the 
results presented here (Table 4) demonstrate that 
steroids with a similar structure do cross-react 
significantly. However. this is not a problem when the 
extraction procedure is incorporated with a specific 
RIA. The elution profiles (Table 4) demonstrated 
that unbound steroid is removed by washing with 
water, while a wash with methanol is extremely 
efficient at removing the bound steroid. This tech- 
nique is currently being investigated for the 
purification of radiolabelled steroid derivatives fol- 
lowing iodination 
Unlike the previous report [13] the technique used 
here produced negligible assay blanks in either the 
testosterone or oestradiol assays. Comparison with 
other extraction systems and recovery estimates indi- 
cated that affinity chromatography is a reliable and 
repeatable technique and is therefore a suitable 
extraction procedure for steroids, as recently 
demonstrated for small molecular weight protein 
hormones [34]. The use of radioiodinated ligands in 
the radioimmunoassay, in conjunction with affinity 
chromatography, has a dual advantage of firstly, 
allowing individual recovery estimates on each sam- 
ple and secondly, removes the need for extracting the 
standards [ 131. Moreover, only one extraction step 
would suffice for samples being assayed for more than 
one hormone. Antibody-Sepharose for each of the 
hormones to be measured, could be pooled followed 
by specific RIA’s for each of the hormones being 
measured. 
In conclusion, we have demonstrated that by judi- 
cial selection of antibody and radioiodinated label 
very precise and sensitive assays can be obtained. In 
addition the incorporation of these assay systems 
with an affinity chromatography extraction pro- 
cedure allows the measurement of low concentrations 
of steroids in large volumes of a range of biological 
fluids. 
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